Latest Prasco Laboratories Stories
- Prasco to market the Authorized Generic of EVISTA® in the United States CINCINNATI, April 1, 2014 /PRNewswire/ -- Prasco Laboratories, announced today it has signed a marketing and distribution agreement with Eli Lilly and Company (NYSE: LLY) to market the Authorized Generic (AG) version of EVISTA(®) (raloxifene hydrochloride tablets), in 60 mg strength in the United States. Prasco will begin shipping the product immediately. The financial terms of the agreement were not...
- Good cheer; viands.
- To revel; to feast.